Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database
Mev Dominguez–Valentin(Norwegian Cancer Society), Maria Grazia Tibiletti(University of Insubria), Áine Stakelum(Hospital Italiano de Buenos Aires), Bernard Rossi(Vita-Salute San Raffaele University), D. C. Winter(St. Vincent's University Hospital), Karin Alvarez-Valenzuela(University of Vermont), Annika Lindblom(Karolinska University Hospital), Stefan Aretz(University of Bonn), Toni T. Seppälä(University of Helsinki), Dirce Maria Carraro(University of Vermont), Karl Heinimann(University Hospital of Basel), John Burn(Newcastle University), Giulia Martina Cavestro(University of Parma), Christoph Engel(University Hospital Leipzig), Gabriel Capellá(Institut Català d'Oncologia), Lucio Bertario(European Institute of Oncology), Francisco Lopez-Koestner(University of Vermont), Julian R. Sampson(Cardiff University), Elizabeth Half(Rambam Health Care Campus), Zohar Levi(University of Vermont), Francesc Balaguer(Universitat de Barcelona), E Vainer(University of Vermont), Luigi Laghi(Humanitas University), Kevin Monahan(St. Mark's Hospital), Harsh Sheth(Hebrew University of Jerusalem), Mábel Bohórquez(Vita-Salute San Raffaele University), Elke Holinski‐Feder(Garvan Institute of Medical Research), Leonardo S. Lino‐Silva(Tecnológico de Monterrey), Maartje Nielsen(University Medical Center Groningen), Nathan Gluck(Tel Aviv University), Marc S. Greenblatt(University of Vermont), Karoline Horisberger(University of Vermont), Inge Bernstein(Aalborg University Hospital), Naim Abu‐Freha(University of Vermont), Robert Fruscio(Azienda Ospedaliera San Gerardo), Rory Kennelly(St. Vincent's University Hospital), Finlay Macrae(The Royal Melbourne Hospital), John‐Paul Plazzer(University of Vermont), Lone Sunde(Aalborg University Hospital), Ingrid Winship, Bernardo Bonanni(European Institute of Oncology), Rolf H. Sijmons(University Medical Center Groningen), Saskia Haupt(Heidelberg University), Ido Laish(Hebrew University of Jerusalem), Adriana Della Valle(Hospital Central de las Fuerzas Armadas), D. Gareth Evans(Manchester Academic Health Science Centre), Carlos Vaccaro(Hospital Italiano de Buenos Aires), Mark A. Jenkins(The University of Melbourne), Tadeusz Dębniak(International Hereditary Cancer Center), Lior H. Katz(Sheba Medical Center)
Cited by 120
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k